De krisis fan antibiotikumresistinsje krijt net it omtinken dat it fertsjinnet
December 22, 2025 · Frisian News
Bacteria resistant to antibiotics kill hundreds of thousands of people yearly, yet governments and media ignore the threat while pouring resources into trendy health causes. Scientists warn that without urgent action, routine surgery could become deadly within a decade.
FryskMinsken geane nei it sikehûs foar rûtineprosedures en keare werom mei resistente bakteriële ynfeksjes dy't standert antibiotika net bestriden kinne. Sokke gefallen helje amper lokaal nijs. Underwilens jouwe sûnensinstânsjes miljarden út oan bewustwêzingskampanjes foar sykten dy't folle minder minsken deadzje, wylst antibiotikumresistinsje hast gjin oerheidfinansiering of media-omtinken krijt bûten spesjalisearre tydskriften.
Resistente baktearjes deadzje wrâldwiid nei skatting 1,27 miljoen minsken per jier, neffens ûndersyk publisearre yn The Lancet. Dochs behannelje regearingen it as in lyts burokratysk probleem. De Wrâldsûnensorganisaasje neamt resistinsje in 'stille pandemy', mar stille pandemyen bewege donors net of driuwe koppen. Sûnensministers bywenje konferinsjes, jouwe ferklearrings ôf en dogge neat konkreets. Farmaseutyske bedriuwen hawwe harren ynvestearringen yn nije antibiotika drastysk weromskroefd omdat winstmarges te lyts binne. In genêsmiddel brûkt foar tsien dagen leveret harren minder op as in kankerpil dy't jierren ynnomd wurdt.
It probleem fersnelt himsels. Sikehûzen brûke antibiotika te folle omdat goedkeapere breed-spektrum genêsmiddels flugger wurkje as rjochte behannelings. Buorderijen goaie antibiotika yn feefoer om groei te stimulearjen, wêrtroch de perfekte briedplak foar resistente stammen ûntstiet. Artsen yn earme lannen diele antibiotika út sûnder tests of ferfolgbesites omdat diagnostyske helpmiddels jild kostje dat se net hawwe. Elke resistente baktearje dy't oerlibbet, jout har genen troch oan oaren. De baktearjes wurde sterker wylst ús ark stomper wurdt.
Rûtine-operaasjes dreigje in gok mei de dea te wurden. In knijeoperaasje, in keizersneed, in blynedarmoperaasje kin jo deadzje troch in sekundêre ynfeksje dy't jo lichem net bestride kin. Kankerkemoterapy wurdt ûnmooglik omdat pasinten de ynfeksjes net oerlibje kinne dy't it feroarsaket. Orgaantransplantaasjes stopje. Toskenheelkunde stopet. De medyske ferwurvenissen fan de lêste santich jier wurde ûngedien makke, net yn in dramatyske ynstorting mar yn in stadige weromtrekking nei in tiid dêr't wy neat fan dizze dingen hienen. Sûnensbureaukraten witte dit. Se publisearje dêr artikels oer. Se dogge neat.
De oplossing bestiet mar fereasket kollektyf hanneljen dat gjin inkeld lân allinnich ôfdwinge kin. Regearingen moatte ûndersyk nei antibiotika finansierje mei deselde urginsje as romteprogramma's. Buorderijen moatte ophâlde mei it dosearjen fan sûne bisten. Sikehûzen moatte teste foardat se behannelje. Wolgestelde lannen moatte earme lannen helpe diagnostyske kapasiteit op te bouwen. Neat fan dit bart omdat antibiotika gjin kranten ferkeapje en resistinsje de kiezers dêr't politisy om jouwe net bang makket. Wy wachtsje oant de krisis net mear te loochenje is, lykas wy altyd dogge.
People go to hospital for routine procedures and return with resistant bacterial infections that standard antibiotics cannot touch. Such cases barely make local news. Meanwhile, health agencies spend billions on disease awareness campaigns for conditions that kill far fewer people, while antibiotic resistance receives almost no public funding or media attention outside specialist journals.
Resistant bacteria kill an estimated 1.27 million people worldwide each year, according to research published in The Lancet. Yet governments treat it as a minor bureaucratic problem. The World Health Organization calls resistance a "silent pandemic," but silent pandemics do not move donors or drive headlines. Health ministers attend conferences, release statements, and do nothing concrete. Pharmaceutical companies have drastically cut investment in new antibiotics because profit margins are too thin. A drug used for ten days earns them less than a cancer pill taken for years.
The problem accelerates itself. Hospitals overuse antibiotics because cheaper broad-spectrum drugs work faster than targeted treatments. Farms pour antibiotics into livestock feed to boost growth, creating the perfect breeding ground for resistant strains. Doctors in poor countries dispense antibiotics without tests or follow-up because diagnostic tools cost money they do not have. Each resistant bacterium that survives spreads its genes to others. The bacteria get stronger while our tools grow duller.
Routine surgery risks becoming a gamble with death. A knee operation, a C-section, a appendix removal could kill you from a secondary infection your body cannot fight. Cancer chemotherapy becomes impossible because patients cannot survive the infections it triggers. Organ transplants stop. Dentistry stops. The medical achievements of the last seventy years unwind quietly, not in a dramatic collapse but in a steady retreat to a time when we had none of these things. Health bureaucrats know this. They publish papers about it. They do nothing.
The solution exists but requires collective action that no single nation can force. Governments must fund antibiotic research with the same urgency they fund space programs. Farms must stop dosing healthy animals. Hospitals must test before they treat. Wealthy nations must help poor ones build diagnostic capacity. None of this happens because antibiotics do not sell newspapers and resistance does not frighten the voters that politicians care about. We wait for the crisis to become undeniable, as we always do.
Published December 22, 2025 · Frisian News · Ljouwert, Fryslân